{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Solution&page=2", "query": { "intervention": "Vehicle Solution", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Vehicle+Solution&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-12T02:11:56.184Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02563899", "title": "Pharmacokinetic, Safety, Tolerability, and Clinical Effect of Topical Umeclidinium in Primary Axillary Hyperhidrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperhidrosis" ], "interventions": [ { "name": "Umeclidinium", "type": "DRUG" }, { "name": "Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 28, "start_date": "2015-11-23", "completion_date": "2016-02-25", "has_results": true, "last_update_posted_date": "2018-10-11", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 2, "location_summary": "Raleigh, North Carolina • Austin, Texas", "locations": [ { "city": "Raleigh", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02563899" }, { "nct_id": "NCT05451329", "title": "A Phase 2 Double-masked Study of VVN539 in Subjects With Elevated Intraocular Pressure", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "VVN539 Ophthalmic Solution 0.02%", "type": "DRUG" }, { "name": "VVN539 Ophthalmic Solution 0.04%", "type": "DRUG" }, { "name": "VVN539 Ophthalmic Solution Vehicle", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "VivaVision Biotech, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 68, "start_date": "2022-07-12", "completion_date": "2022-12-22", "has_results": true, "last_update_posted_date": "2024-01-17", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "Durham, North Carolina", "locations": [ { "city": "Durham", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT05451329" }, { "nct_id": "NCT05294328", "title": "Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of Presbyopia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Presbyopia", "Refractive Errors", "Eye Diseases" ], "interventions": [ { "name": "Aceclidine+Brimonidine combination ophthalmic solution", "type": "DRUG" }, { "name": "Aceclidine ophthalmic solution", "type": "DRUG" }, { "name": "Vehicle Proprietary Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "LENZ Therapeutics, Inc", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "45 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "45 Years to 75 Years" }, "enrollment_count": 68, "start_date": "2022-05-05", "completion_date": "2022-09-10", "has_results": true, "last_update_posted_date": "2024-09-05", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 5, "location_summary": "Glendale, California • Indianapolis, Indiana • Andover, Massachusetts + 2 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Andover", "state": "Massachusetts" }, { "city": "Memphis", "state": "Tennessee" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05294328" }, { "nct_id": "NCT02962050", "title": "Delineating Swallowing Impairment and Decline in ALS", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Amyotrophic Lateral Sclerosis" ], "interventions": [ { "name": "Videofluoroscopic Swallowing Study (VFSS)", "type": "PROCEDURE" }, { "name": "Voluntary Peak Cough Flow Testing", "type": "DEVICE" }, { "name": "Iowa Oral Performance Instrument", "type": "DEVICE" }, { "name": "Capsaicin Challenge", "type": "DRUG" }, { "name": "Pulmonary Function Testing", "type": "DEVICE" }, { "name": "Eating Assessment Tool 10", "type": "OTHER" }, { "name": "The Center for Neurologic Study Bulbar Function Scale", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DEVICE", "DRUG", "OTHER" ], "sponsor": "University of Florida", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "90 Years", "sex": "ALL", "summary": "18 Years to 90 Years" }, "enrollment_count": 109, "start_date": "2017-05-31", "completion_date": "2023-02-16", "has_results": false, "last_update_posted_date": "2023-02-23", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 2, "location_summary": "Gainesville, Florida • Tampa, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02962050" }, { "nct_id": "NCT04057833", "title": "E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Rotator Cuff Tears", "Muscle Atrophy or Weakness", "Tendon Rupture - Shoulder", "Safety Issues" ], "interventions": [ { "name": "E-CEL UVEC", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hospital for Special Surgery, New York", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "45 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "45 Years to 70 Years" }, "enrollment_count": 20, "start_date": "2019-11-20", "completion_date": "2026-10", "has_results": false, "last_update_posted_date": "2026-08-20", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04057833" }, { "nct_id": "NCT07264517", "title": "Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye Disease (DED).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "GRF312 5%", "type": "DRUG" }, { "name": "Placebo Comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Instituto Grifols, S.A.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 103, "start_date": "2025-11-03", "completion_date": "2026-05-20", "has_results": false, "last_update_posted_date": "2026-06-16", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 10, "location_summary": "Glendale, California • Grove, California • Newport Beach, California + 7 more", "locations": [ { "city": "Glendale", "state": "California" }, { "city": "Grove", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Morrow", "state": "Georgia" }, { "city": "Carmel", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT07264517" }, { "nct_id": "NCT03452033", "title": "H-1337 Ophthalmic Solution Phase 1/2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Glaucoma, Open-Angle" ], "interventions": [ { "name": "H-1337 Placebo", "type": "DRUG" }, { "name": "H-1337 [1]", "type": "DRUG" }, { "name": "H-1337 [2]", "type": "DRUG" }, { "name": "H-1337 [3]", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allysta Pharmaceutical", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 87, "start_date": "2018-03-15", "completion_date": "2018-08-15", "has_results": true, "last_update_posted_date": "2022-07-12", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "Goose Creek, South Carolina", "locations": [ { "city": "Goose Creek", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT03452033" }, { "nct_id": "NCT05062330", "title": "The TRANQUILITY 2 Trial: A Phase 3 Clinical Trial to Assess the Efficacy and Safety in Subjects With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "Reproxalap Ophthalmic Solution (0.25%)", "type": "DRUG" }, { "name": "Vehicle Ophthalmic Solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aldeyra Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 361, "start_date": "2021-08-28", "completion_date": "2022-03-04", "has_results": true, "last_update_posted_date": "2025-03-18", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "Raynham, Massachusetts", "locations": [ { "city": "Raynham", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05062330" }, { "nct_id": "NCT03879863", "title": "The RENEW Trial: A Multi-Center, Randomized, Double-Masked, Parallel-Group, Vehicle-Controlled, Adaptive Phase 3 Clinical Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Dry Eye" ], "interventions": [ { "name": "Reproxalap Ophthalmic Solution (0.25%) QID", "type": "DRUG" }, { "name": "Vehicle Ophthalmic Solution QID", "type": "DRUG" }, { "name": "Reproxalap Ophthalmic Solution (0.25%) QID to BID", "type": "DRUG" }, { "name": "Vehicle Ophthalmic Solution QID to BID", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aldeyra Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 422, "start_date": "2019-04-16", "completion_date": "2019-10-04", "has_results": true, "last_update_posted_date": "2025-01-23", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "Newport Beach, California", "locations": [ { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03879863" }, { "nct_id": "NCT06833320", "title": "Propranolol Treatment for Postoperative Chylothorax", "overall_status": "SUSPENDED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Postoperative Chylothorax", "Congenital Heart Disease", "Open Heart Surgery", "Chylothorax" ], "interventions": [ { "name": "Propranolol Hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "June Wu", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "7 Days", "maximum_age": "18 Years", "sex": "ALL", "summary": "7 Days to 18 Years" }, "enrollment_count": 50, "start_date": "2025-09-09", "completion_date": "2031-01-01", "has_results": false, "last_update_posted_date": "2026-05-15", "last_synced_at": "2026-09-12T02:11:56.184Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06833320" } ] }